BUILDING OUT HHS’ LEADERSHIP — Two of President Donald Trump’s choices to lead major health agencies will face Senate confirmation this week, while two others will be voted on by key Senate committees. Why it matters: The nominees will work with HHS Secretary Robert F. Kennedy Jr. on his planned overhaul of the health care system. On Thursday, the Senate Health, Education, Labor and Pensions Committee will vote on whether to approve Dr. Marty Makary as FDA commissioner and Dr. Jay Bhattacharya as NIH director. Also this week, former House representative Dr. Dave Weldon, nominated as CDC director, and television personality Dr. Mehmet Oz, nominated as CMS administrator, will meet with Senate leaders. Weldon will appear before the Senate HELP Committee on Thursday, POLITICO’s Sophie Gardner reports. It will be the first time a CDC director will require Senate confirmation, thanks to a law passed by Congress in 2022. What to expect: Weldon, a Florida House rep from 1995 to 2011, will likely be pressed by Democrats and some Republicans on his past statements linking vaccines and autism. During his time in Congress, he repeatedly questioned the safety of vaccines and introduced a bill to shift vaccine safety oversight from the CDC to an independent agency within HHS. Oz will appear before the Senate Finance Committee on Friday, POLITICO’s Robert King reports. If confirmed, Oz would manage Medicare, Medicaid and Obamacare’s insurance exchanges. What to expect: Key Republicans, including HELP Chair Bill Cassidy of Louisiana and Sen. Susan Collins of Maine, support Oz. But it remains unclear whether he would garner any Democratic support. Oz will likely face questions from skeptical Democrats about how he would oversee the Medicare Advantage program, where older Americans can join a privately run plan. The program has surged in popularity with more than 31 million participants, more than half of total Medicare enrollment. Democrats — and some Republicans — are concerned about overpayments to Medicare Advantage plans, the high rate of care denials and deceptive marketing. Another possible area of questioning is the Department of Government Efficiency initiative run by billionaire Elon Musk. The panel’s top Democrat, Sen. Ron Wyden of Oregon, and Sen. Angus King (I–Maine) recently asked CMS’ acting director whether more agency firings are expected. CMS fired more than 80 people in its insurance oversight division and a handful of people in its innovation center, although some innovation workers were rehired. WELCOME TO MONDAY PULSE. In case you missed it, our colleagues on the Congress team got lawmakers to dish on what Congress is really like, and you’re going to want to read it. Send your tips, scoops and feedback to ccirruzzo@politico.com and khooper@politico.com and follow along @ChelseaCirruzzo and @Kelhoops.
|